207.00
0.00
(0.00%)
At close: January 14 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
866,300.00
746,400.00
612,300.00
701,900.00
416,878.00
Investing Cash Flow
-365,000.00
-2,722,700.00
-957,500.00
-465,200.00
-621,116.00
Financing Cash Flow
-117,600.00
1,986,100.00
220,700.00
-77,700.00
234,066.00
End Cash Position
483,000.00
116,600.00
107,100.00
223,600.00
59,762.00
Capital Expenditure
-362,600.00
-473,600.00
-430,600.00
-324,000.00
-159,192.00
Issuance of Debt
13,600.00
2,649,200.00
566,800.00
74,200.00
334,788.00
Repayment of Debt
-982,600.00
-326,400.00
-174,400.00
-79,700.00
-35,322.00
Free Cash Flow
503,700.00
272,800.00
181,700.00
377,900.00
416,878.00
12/31/2020 - 8/3/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SUVPF Sartorius Aktiengesellschaft
214.66
0.00%
1SXP.HM Schott Pharma AG & CO KGaA
24.20
-2.97%
1SXP.F SCHOTT Pharma AG & Co. KGaA
24.20
-2.97%
SSSGY Sartorius Aktiengesellschaft
36.53
0.00%
1SXP.VI SCHOTT Pharma AG & Co. KGaA
24.34
-0.16%
1SXP.DE SCHOTT Pharma AG & Co. KGaA
24.24
-0.57%
SRT.SG Sartorius AG
189.00
+1.07%
RGEN Repligen Corporation
156.55
-1.19%
MBOT Microbot Medical Inc.
1.5400
-13.48%
GCTK GlucoTrack, Inc.
0.1220
-18.50%